High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMs DOI Creative Commons
Tony P. Huang, Zachary Heins, Shannon M. Miller

и другие.

Nature Biotechnology, Год журнала: 2022, Номер 41(1), С. 96 - 107

Опубликована: Сен. 8, 2022

Despite the availability of Cas9 variants with varied protospacer-adjacent motif (PAM) compatibilities, some genomic loci-especially those pyrimidine-rich PAM sequences-remain inaccessible by high-activity proteins. Moreover, broadening sequence compatibility through engineering can increase off-target activity. With directed evolution, we generated four that together enable targeting most sequences in human genome. Using phage-assisted noncontinuous evolution and eVOLVER-supported continuous evolved Nme2Cas9, a compact variant, into recognize single-nucleotide pyrimidine-PAM sequences. We developed general selection strategy requires functional editing fully specified target protospacers PAMs. applied this to evolve eNme2-T.1, eNme2-T.2, eNme2-C eNme2-C.NR. Variants eNme2-T.1 eNme2-T.2 offer access N

Язык: Английский

CRISPR/Cas-based nucleic acid detection strategies: Trends and challenges DOI Creative Commons
Jian Zhou, Zhuo Li, Joshua Seun Olajide

и другие.

Heliyon, Год журнала: 2024, Номер 10(4), С. e26179 - e26179

Опубликована: Фев. 1, 2024

CRISPR/Cas systems have become integral parts of nucleic acid detection apparatus and biosensors. Various such as CRISPR/Cas9, CRISPR/Cas12, CRISPR/Cas13, CRISPR/Cas14 CRISPR/Cas3 utilize different mechanisms to detect or differentiate biological activities nucleotide sequences. Usually, CRISPR/Cas-based are combined with polymerase chain reaction, loop-mediated isothermal amplification, recombinase amplification transcriptional technologies for effective diagnostics. Premised on these, many biosensors been developed acids viral bacterial pathogens in clinical samples, well other applications life sciences including biosecurity, food safety environmental assessment. Additionally, showed better specificity compared molecular diagnostic methods. In this review, we give an overview various methods highlight some advances their development components. We also discourse operational challenges advantages disadvantages systems. Finally, important considerations offered the improvement testing.

Язык: Английский

Процитировано

23

Rapid in silico directed evolution by a protein language model with EVOLVEpro DOI
Kaiyi Jiang, Zhaoqing Yan, Matteo Di Bernardo

и другие.

Science, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 21, 2024

Directed protein evolution is central to biomedical applications but faces challenges like experimental complexity, inefficient multi-property optimization, and local maxima traps. While in silico methods using language models (PLMs) can provide modeled fitness landscape guidance, they struggle generalize across diverse families map activity. We present EVOLVEpro, a few-shot active learning framework that combines PLMs regression rapidly improve EVOLVEpro surpasses current methods, yielding up 100-fold improvements desired properties. demonstrate its effectiveness six proteins RNA production, genome editing, antibody binding applications. These results highlight the advantages of with minimal data over zero-shot predictions. opens new possibilities for AI-guided engineering biology medicine.

Язык: Английский

Процитировано

21

Epigenome editing technologies for discovery and medicine DOI

Sean R. McCutcheon,

Dahlia Rohm,

Nahid Iglesias

и другие.

Nature Biotechnology, Год журнала: 2024, Номер 42(8), С. 1199 - 1217

Опубликована: Июль 29, 2024

Язык: Английский

Процитировано

18

Robust genome editing activity and the applications of enhanced miniature CRISPR-Cas12f1 DOI Creative Commons
Soo-Ji Park,

Sungjin Ju,

Won Jun Jung

и другие.

Nature Communications, Год журнала: 2025, Номер 16(1)

Опубликована: Янв. 15, 2025

Abstract With recent advancements in gene editing technology using the CRISPR/Cas system, there is a demand for more effective editors. A key factor facilitating efficient CRISPR delivery into cells, which known to be associated with size of system. Accordingly, compact CRISPR-Cas systems derived from various strains are discovered, among Un1Cas12f1 2.6 times smaller than SpCas9, providing advantages therapy research. Despite extensive engineering efforts improve Un1Cas12f1, efficiency still shown low depending on target site. To overcome this limitation, we develop enhanced Cas12f1 (eCas12f1), exhibits activity similar SpCas9 and AsCpf1, even targets where previously improved variants showed efficiency. Furthermore, demonstrate that eCas12f1 efficiently induces apoptosis cancer cells compatible base regulation expression, verifying its high utility applicability

Язык: Английский

Процитировано

2

High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMs DOI Creative Commons
Tony P. Huang, Zachary Heins, Shannon M. Miller

и другие.

Nature Biotechnology, Год журнала: 2022, Номер 41(1), С. 96 - 107

Опубликована: Сен. 8, 2022

Despite the availability of Cas9 variants with varied protospacer-adjacent motif (PAM) compatibilities, some genomic loci-especially those pyrimidine-rich PAM sequences-remain inaccessible by high-activity proteins. Moreover, broadening sequence compatibility through engineering can increase off-target activity. With directed evolution, we generated four that together enable targeting most sequences in human genome. Using phage-assisted noncontinuous evolution and eVOLVER-supported continuous evolved Nme2Cas9, a compact variant, into recognize single-nucleotide pyrimidine-PAM sequences. We developed general selection strategy requires functional editing fully specified target protospacers PAMs. applied this to evolve eNme2-T.1, eNme2-T.2, eNme2-C eNme2-C.NR. Variants eNme2-T.1 eNme2-T.2 offer access N

Язык: Английский

Процитировано

69